CD40LG and neoplasm: CD40 activation of APC plays an important role in driving anti-tumor T cell-mediated immune responses, and agonist CD40 antibodies which mimic the action of CD40 ligand are thought to represent promising therapeutics for novel immune strategies for cancer [9].